rs117183725

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_173630.4(RTTN):​c.6015C>T​(p.Ala2005Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00905 in 1,613,954 control chromosomes in the GnomAD database, including 93 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0094 ( 90 hom. )

Consequence

RTTN
NM_173630.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.395

Publications

2 publications found
Variant links:
Genes affected
RTTN (HGNC:18654): (rotatin) This gene encodes a large protein whose specific function is unknown. Absence of the orthologous protein in mouse results in embryonic lethality with deficient axial rotation, abnormal differentiation of the neural tube, and randomized looping of the heart tube during development. In human, mutations in this gene are associated with polymicrogyria with seizures. In human fibroblasts this protein localizes at the ciliary basal bodies. Given the intracellular localization of this protein and the phenotypic effects of mutations, this gene is suspected of playing a role in the maintenance of normal ciliary structure which in turn effects the developmental process of left-right organ specification, axial rotation, and perhaps notochord development. [provided by RefSeq, Jan 2013]
RTTN Gene-Disease associations (from GenCC):
  • microcephalic primordial dwarfism due to RTTN deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • bilateral generalized polymicrogyria
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 18-70020753-G-A is Benign according to our data. Variant chr18-70020753-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.395 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00602 (917/152284) while in subpopulation NFE AF = 0.00926 (630/68022). AF 95% confidence interval is 0.00866. There are 3 homozygotes in GnomAd4. There are 448 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTTNNM_173630.4 linkc.6015C>T p.Ala2005Ala synonymous_variant Exon 45 of 49 ENST00000640769.2 NP_775901.3 Q86VV8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTTNENST00000640769.2 linkc.6015C>T p.Ala2005Ala synonymous_variant Exon 45 of 49 2 NM_173630.4 ENSP00000491507.1 Q86VV8-1

Frequencies

GnomAD3 genomes
AF:
0.00604
AC:
919
AN:
152166
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00220
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00439
Gnomad ASJ
AF:
0.00691
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00850
Gnomad FIN
AF:
0.00443
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00926
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.00704
AC:
1753
AN:
248862
AF XY:
0.00748
show subpopulations
Gnomad AFR exome
AF:
0.00161
Gnomad AMR exome
AF:
0.00389
Gnomad ASJ exome
AF:
0.00607
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00640
Gnomad NFE exome
AF:
0.00900
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.00936
AC:
13688
AN:
1461670
Hom.:
90
Cov.:
31
AF XY:
0.00935
AC XY:
6796
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.00218
AC:
73
AN:
33472
American (AMR)
AF:
0.00394
AC:
176
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00609
AC:
159
AN:
26128
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39696
South Asian (SAS)
AF:
0.0100
AC:
863
AN:
86246
European-Finnish (FIN)
AF:
0.00689
AC:
368
AN:
53416
Middle Eastern (MID)
AF:
0.0262
AC:
151
AN:
5768
European-Non Finnish (NFE)
AF:
0.0102
AC:
11328
AN:
1111844
Other (OTH)
AF:
0.00931
AC:
562
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
666
1332
1999
2665
3331
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00602
AC:
917
AN:
152284
Hom.:
3
Cov.:
32
AF XY:
0.00602
AC XY:
448
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00219
AC:
91
AN:
41550
American (AMR)
AF:
0.00438
AC:
67
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00691
AC:
24
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00809
AC:
39
AN:
4820
European-Finnish (FIN)
AF:
0.00443
AC:
47
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00926
AC:
630
AN:
68022
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
45
90
134
179
224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00787
Hom.:
3
Bravo
AF:
0.00597
Asia WGS
AF:
0.00664
AC:
24
AN:
3478
EpiCase
AF:
0.00999
EpiControl
AF:
0.00860

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RTTN: BP4, BP7, BS1, BS2 -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Feb 07, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
5.9
DANN
Benign
0.42
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117183725; hg19: chr18-67687989; API